Berkeley Communications
HTA in the news
Insurers, Employers Face Pressure to Match Trump Deals on Drugs
Bloomberg Law
The Trump administration’s deal to lower the cash price of blockbuster weight-loss drugs is heightening pressure on employers and insurers to negotiate better costs with the drugmakers, say lawyers, academics, and executives.
Read moreObesity Drugs May Drop to as Little as $150 a Month
The New York Times
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay their own money.
Read moreTrumpRx Pfizer Drug Pricing
Pharmacy Practice News
The Trump administration’s newly unveiled “TrumpRx” initiative—a partnership with Pfizer framed as the first step toward applying most-favored-nation (MFN) drug pricing in the United States—is being touted as a game changer in making prescription drugs more affordable.
Read moreTrumpRx Pfizer Drug Pricing
Specialty Pharmacy Continuum
The Trump administration’s newly unveiled “TrumpRx” initiative—a partnership with Pfizer framed as the first step toward applying most-favored-nation (MFN) drug pricing in the United States—is being touted as a game changer in making prescription drugs more affordable.
Read moreEnd of Premium Tax Credits Could Hit Hospitals Financially
Medscape
Enrollment in the Affordable Care Act (ACA) Marketplace has doubled since the introduction of enhanced premium tax credits in 2021, providing health insurance coverage for more than 24 million Americans.
Read moreThe policies top of mind for healthcare stakeholders right now.
Fierce Healthcare’s Podnosis Podcast
Amid a breakneck pace of regulatory changes under the Trump administration, healthcare stakeholders are scrambling to keep up.
Listen nowEmployers find success in healthcare savings through TPA shift and payment integrity
Healthcare Financial Management Association
Tiering and steering designs in their employee health plans also have driven 11% to 12% reductions in healthcare costs.
Read moreTrumpRx Effects on Medicaid Rebates, Cost-Shifting, and Value-Based Drug Pricing: Robert Andrews
American Journal of Managed Care
Robert Andrews, CEO of the Health Transformation Alliance, addresses Medicaid rebates, cost-shifting concerns, and value-based pricing trends.
Read more